Intensive insulin therapy and mortality in critically ill patients
Open Access
- 29 February 2008
- journal article
- research article
- Published by Springer Nature in Critical Care
- Vol. 12 (1) , R29
- https://doi.org/10.1186/cc6807
Abstract
Introduction: Intensive insulin therapy (IIT) with tight glycemic control may reduce mortality and morbidity in critically ill patients and has been widely adopted in practice throughout the world. However, there is only one randomized controlled trial showing unequivocal benefit to this approach and that study population was dominated by post-cardiac surgery patients. We aimed to determine the association between IIT and mortality in a mixed population of critically ill patients. Methods: We conducted a cohort study comparing three consecutive time periods before and after IIT protocol implementation in a Level 1 trauma center: period I (no protocol); period II, target glucose 80 to 130 mg/dL; and period III, target glucose 80 to 110 mg/dL. Subjects were 10,456 patients admitted to intensive care units (ICUs) between 1 March 2001 and 28 February 2005. The main study endpoints were ICU and hospital mortality, Sequential Organ Failure Assessment score, and occurrence of hypoglycemia. Multivariable regression analysis was used to evaluate mortality and organ dysfunction during periods II and III relative to period I. Results: Insulin administration increased over time (9% period I, 25% period II, and 42% period III). Nonetheless, patients in period III had a tendency toward higher adjusted hospital mortality (odds ratio [OR] 1.15, 95% confidence interval [CI] 0.98, 1.35) than patients in period I. Excess hospital mortality in period III was present primarily in patients with an ICU length of stay of 3 days or less (OR 1.47, 95% CI 1.11, 1.93 There was an approximately fourfold increase in the incidence of hypoglycemia from periods I to III. Conclusion: A policy of IIT in a group of ICUs from a single institution was not associated with a decrease in hospital mortality. These results, combined with the findings from several recent randomized trials, suggest that further study is needed prior to widespread implementation of IIT in critically ill patients.Keywords
This publication has 52 references indexed in Scilit:
- Clinical Effects of Hyperglycemia in the Cardiac Surgery Population: The Portland Diabetic ProjectEndocrine Practice, 2006
- Admission Hyperglycemia and Other Risk Factors as Predictors of Hospital Mortality in a Medical ICU PopulationChest, 2005
- Relationship between hyperglycemia and symptomatic vasospasm after subarachnoid hemorrhage*Critical Care Medicine, 2005
- Admission Hyperglycemia as a Prognostic Indicator in TraumaPublished by Wolters Kluwer Health ,2003
- Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke TrialNeurology, 2002
- Stress-Induced HyperglycemiaCritical Care Clinics, 2001
- The Influence of Hyperglycemia on Neurological Outcome in Patients with Severe Head InjuryNeurosurgery, 2000
- Glycometabolic State at Admission: Important Risk Marker of Mortality in Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial InfarctionCirculation, 1999
- Blood Glucose Concentration after Cardiopulmonary Resuscitation Influences Functional Neurological Recovery in Human Cardiac Arrest SurvivorsJournal of Cerebral Blood Flow & Metabolism, 1997
- Hyperglycemia and neurological outcome in patients with head injuryJournal of Neurosurgery, 1991